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The frequency with which the yeast [PSI] prion form of
Sup35 arises de novo is controlled by a number of genetic and
environmental factors. We have previously shown that in cells
lacking the antioxidant peroxiredoxin proteins Tsa1 and Tsa2,
the frequency of de novo formation of [PSI] is greatly elevated.
We show here that Tsa1/Tsa2 also function to suppress the for-
mation of the [PIN] prion form of Rnq1. However, although
oxidative stress increases the de novo formation of both [PIN]
and [PSI], it does not overcome the requirement of cells being
[PIN] to form the [PSI] prion. We use an anti-methionine
sulfoxide antibody to show that methionine oxidation is ele-
vated in Sup35 during oxidative stress conditions. Abrogating
Sup35 methionine oxidation by overexpressing methionine
sulfoxide reductase (MSRA) prevents [PSI] formation, indicat-
ing that Sup35 oxidationmay underlie the switch from a soluble
to an aggregated form of Sup35. In contrast, we were unable to
detect methionine oxidation of Rnq1, and MSRA overexpres-
sion did not affect [PIN] formation in a tsa1 tsa2mutant. The
molecular basis of how yeast andmammalian prions form infec-
tious amyloid-like structures de novo is poorly understood. Our
data suggest a causal link between Sup35 protein oxidation and
de novo [PSI] prion formation.
Prions are novel protein-only infectious agents associated
with a group of transmissible neurodegenerative diseases (1).
Prion formation also underlies the unusual genetic behavior of
several non-Mendelian traits found in fungi (2, 3). The most
extensively studied yeast prion [PSI] is an infectious, self-per-
petuating form of Sup35, an essential translation termination
factor (4). When Sup35 shifts to its transmissible prion confor-
mation, it becomes unavailable for translation termination,
resulting in translation of nonsense codons by near cognate
tRNAs (5, 6). Although mammalian prions are associated with
disease, yeast prions can cause epigenetic changes in protein
activity resulting in genetic variability, which can promote
adaption under certain growth conditions (7, 8).
How prions form spontaneously into infectious amyloid-like
structures is poorly understood at the molecular level. The fre-
quency of de novo formation of the [PSI] prion in yeast is
known to be regulated by a number of genetic and environmen-
tal factors (5, 8, 9). For example, for [PSI] to form de novo,
there is an absolute requirement for the cells to carry the [PIN]
prion (10). [PIN] is the prion form of Rnq1, which is a protein
of unknown function. [PIN] prion aggregates appear to act as
imperfect templates on which Sup35 molecules misfold and
assemble into transmissible prion aggregates (11, 12). Clues as
to how the initial misfolding event translates into a stable and
transmissible prion have begun to emerge through the analysis
of a Sup35NM-GFP fusion protein that can be switched to a
heritable prion form by wild-type [PSI] prions. As with wild-
type Sup35, the Sup35NM-GFP fusion protein retains the
unstructuredN-terminal prion-forming domain that has a high
propensity to misfold (13). Any Sup35 molecules that do mis-
fold are transferred to the recently discovered cellular site
known as the insoluble protein deposit, a component of the
quality control machinery in eukaryotic cells that is located
adjacent to the vacuole. The insoluble protein deposit is a site of
accumulation of two different prion proteins (Sup35 and Rnq1)
as well as oxidatively damaged proteins (14, 15). The resulting
localized concentration of such misfolded proteins in a [PIN]
cell together with the aggregated Rnq1 is believed to facilitate
the nucleation of prion protein polymerization in a [PIN]-de-
pendent manner. The transmissible form of the prion is then
formed via a two-stage process that initially involves the forma-
tion of non-transmissible extended polymers of the prion pro-
tein followed by their fragmentation into shorter transmissible
prion protein polymers thatmost likely define the transmissible
entities that are required for continued propagation, i.e.
propagons (15).
Increasing evidence suggests a possible causal link between
protein oxidation and aggregate formation. All organisms are
exposed to reactive oxygen species (ROS)4 during the course of
normal aerobic metabolism or following exposure to radical-
generating compounds (16). ROS are toxic agents that can
damage a wide variety of cellular components, and oxidative
damage to amino acid residues in proteins is a well established
trigger of protein misfolding (17). For example, oxidative dam-
age to Met residues in purified PrPC may cause the -to-
structural conversion, which underlies the sporadic formation
of PrPSc (18, 19). Oxidation of Met-35 has been detected in
amyloid- peptide from Alzheimer disease patients, which
may contribute to the neuronal cytoskeletal disruption that is
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characteristic of the disease (20). Oxidative stress may also play
a role in modulating -synuclein aggregation in Parkinson dis-
ease because formation of -synuclein-soluble oligomers has
been shown to require methionine oxidation (21), and clear-
ance of -synuclein oligomers is inhibited in methionine sulf-
oxide reductase mutants (22). Protein oxidation may therefore
be a common mechanism underlying the aggregation of mam-
malian amyloidogenic proteins.
Oxidative stress induced by exposure to H2O2 elevates the
frequency of de novo [PSI] formation (8). Additionally, the
frequency of [PSI] prion formation is significantly elevated in
mutants lacking theTSA1 andTSA2peroxiredoxins (Prxs) (23).
Prxs are ubiquitous, thiol-specific proteins that have multiple
functions in stress protection, including oxidative stress (24,
25). In yeast, Tsa1 is the major 2-Cys Prx and acts as an antiox-
idant in the detoxification of hydroperoxides (26, 27), particu-
larly as a result of endogenous ROS generated during normal
aerobic metabolism (28). The Tsa2 peroxiredoxin is highly
homologous to Tsa1 (86% amino acid identity) and possesses
similar peroxidase activity, although it is normally expressed at
significantly lower levels when compared with Tsa1 (27, 29).
Tsa1 and Tsa2 co-localize to ribosomes and function to protect
Sup35 against oxidative stress-induced formation of its herita-
ble [PSI] prion conformation (23). Molecular oxygen is
required for [PSI] prion formation because growth under
anaerobic conditions prevents prion formation in the tsa1 tsa2
mutant. Conversely, oxidative stress conditions induced by
exposure to hydrogen peroxide elevates the rate of de novo
[PSI] prion formation leading to increased suppression of all
three termination codons in the tsa1 tsa2 mutant (23). Taken
together, these data suggest oxidative damage as being one of
the triggers of de novo [PSI] prion formation. However, it is
unclear whether ROS directly oxidize Sup35 or whether ROS
cause alterations in the protein homeostasis network, which
result in increased [PSI] prion formation.
In this study, we show that Tsa1 and Tsa2 function to sup-
press the formation of another unrelated prion, [PIN], the
prion formof the glutamine and asparagines-richRnq1 protein,
but increased protein aggregation per se does not appear to be a
common feature of prion and amyloidogenic proteins in tsa1
tsa2 mutants. Although oxidative stress increases the de novo
formation of the [PSI] prion, it does not overcome the require-
ment of cells being [PIN] to form the [PSI] prion.We further
show a correlation betweenmethionine oxidation in Sup35 and
[PSI] prion formation, confirming a link between Sup35 oxi-
dative damage and de novo prion formation.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids—The wild-type strain W303
(MATa ura3-52 leu2-3 leu2-112 trp1-1 ade2-1 his3-11 can1-
100) and its isogenic derivatives deleted for TSA1 (tsa1::LEU2
or tsa1::URA3) and TSA2 (tsa2::KANMX) have been described
previously (23, 30). [PSI], [psi], tsa1::LEU2 tsa2::HIS, and
hsp104::K218T, K620T derivatives of 74D-694 (MATa ade1-14
trp1-289 his3-200 ura3-52 leu2-3,112) have been described
previously (23). Strains were deleted for RNQ1 (rnq1::TRP1 or
rnq1::URA3) in 74D-694 using standard yeast methodology.
Sup35 andRnq1were tagged at their C termini in 74D-694with
a tandemaffinity purification (TAP) tag (31).Overexpression of
methionine sulfoxide reductase (MSRA) was achieved using a
GAL1-MSRA-GST plasmid (pEGH) supplied by Open
Biosystems.
Growth and Stress Conditions—Strains were grown at 30 °C
with shaking at 180 rpm in rich YEPDmedium (2%w/v glucose,
2% w/v bactopeptone, 1% w/v yeast extract) or minimal SD
(0.67% w/v yeast nitrogen base without amino acids, 2% w/v
glucose) supplemented with appropriate amino acids and
bases. SGal media contained 2% w/v galactose in place of glu-
cose. Media were solidified by the addition of 2% (w/v) agar.
Visual differentiation of red/white colony formation was
enhanced by growth on quarter YEPD (qYEPD: 4%w/v glucose,
1% w/v bactopeptone, 0.25% w/v yeast extract). Strains were
cured by growth on YEPD agar plates containing 5 mM guani-
dine hydrochloride (GdnHCl). Sensitivity to hydrogen peroxide
was determined by growing cells to early exponential phase
(A600 0.1) and treating cultures with 100 M H2O2 for 20 h.
Aliquots of cells were diluted in fresh YEPDmedium and plated
in triplicate on YEPD plates to obtain viable counts after 3 days
of growth.
Visualization of Aggregation of Prion and Amyloidogenic
Proteins—De novo [PSI] prion formation was visualized as
described previously using the CUP1-SUP35NM-GFP plasmid
(23). Similarly, Cyc8 was visualized using the CUP1-CYC8-YFP
plasmid (32). Cells were grown to early exponential phase (A600
0.5) in SDminimal media and 50M copper sulfate added for
5 h for induction of the CUP1 promoter. GAL1-controlled
expression plasmids were used for Htt (pYES2-Htt25Q-GFP,
pYES2-Htt103Q-GFP), -synuclein (pHY314-Syn-GFP),
Ure2 (pYe2T-URE2GFP), andRnq1 (GAL1-RNQ1-EGFP) (33–
35). Cultures were grown in non-repressing sucrose media or
inducing galactose media for 2 h to induce GAL1 expression.
Swi1was visualized using the p416TEF-NQYFPplasmid, which
expresses the NQ region of Swi1 as a fusion with YFP under the
control of the constitutive TEF1 promoter (36). Plasmids were
transformed into wt (74D-694 or W303) and tsa1 tsa2mutant
cells and visualized using an Olympus widefield microscope
andMetaVue software (Bioimaging Facility, Faculty of Life Sci-
ence, University of Manchester).
Protein Analysis—The analysis of Sup35 aggregates by sub-
cellular fractionation was performed as described previously
(37). Rnq1 subcellular fractionation was analyzed using a
slightly modified procedure. Briefly, exponential phase cells
(A6000.5) were collected by centrifugation, washed once with
distilled water, and resuspended in 50 l of lysis buffer (74 mM
Tris-HCl, pH 8.0, 150 mM KCl, 50 mM EDTA, 1 mM DTT, 0.2%
w/v SDS, 1% v/v Triton, 1 mM PMSF, Complete mini protease
inhibitor mixture, Roche Applied Science). Cell breakage was
achieved by vortexing at 4 °C with an equal volume of glass
beads. Cell debris was removed by centrifugation at 3000 rpm
for 3 min at 4 °C. Total cell extracts were fractionated by ultra-
centrifugation for 1 h at 85,000  g in a Beckman MLA-130
rotor to generate supernatant and pellet fractions. Pellets were
resuspended in an equivalent volume of lysis buffer to the
supernatant and fractions subjected to SDS-PAGE and West-
ern blot analysis. The analysis of Sup35 amyloid polymers by
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semidenaturing detergent-agarose gel electrophoresis (SDD-
AGE) was performed as described previously (38).
Determination of Spontaneous [PIN] Prion Formation—To
assay spontaneous [PIN] prion formation, wild-type (74D-
694) and tsa1 tsa2 [psi] mutant strains were first transformed
with theCUP1-SUP35NM-GFPplasmid and grown in the pres-
ence of 3 mM GdnHCl to eliminate the [PIN] prion. The
resulting [pin] transformed colonies were grown in SD-Ura
media to early exponential phase (A6000.1) and treated with
100 M H2O2 for 20 h. Cultures were then diluted to A600 
0.0001, and 100 l of diluted cultures were plated onto SD-Ura
plates to generate single colonies following growth at 30 °C for
3 days. 96 individual colonies were inoculated into 150 l of
SD-Ura media containing 25 M CuSO4 in 96-well plates and
incubated overnight at 30 °C/180 rpm. 5 l from each of the 96
cultureswere spotted onto qYEPD, qYEPD 4mMGdnHCl, or
SD-Ade (containing 1%YEPD to improve growth) plates.Over-
expression of Sup35NM-GFP generates [PSI] colonies, which
were scored as white/pink colonies and by their ability to grow
in the absence of adenine, with both phenotypes being curable
with GdnHCl. The rate of [PIN] formation was inferred from
the rate of [PSI] formation, which is entirely dependent on
cells being [PIN] (10).
TAP Affinity Chromatography—Sup35-TAP and Rnq1-TAP
affinity purificationwas based on themethods described byRef.
31. TAP-tagged strains were grown to exponential phase in
minimal SD media. Cultures were harvested by centrifugation,
washedwith ice-coldwater, and resuspended in 300l of buffer
D (20 mM HEPES, pH 7.9, 50 mM KCl, 0.2 mM EDTA, 20% v/v
glycerol, 1mMPMSF, 1Complete EDTA-free protease inhib-
itor mixture tablet, Roche Applied Science, catalog number 04
693 159 001). Cells were broken with glass beads using a Mini-
bead beater (Biospec Scientific, Bartlesville, OK) for 4  30-s
cycles (1-min cool-down between each cycle) at 4 °C. An addi-
tional 200 l of buffer D were added to the lysed cells, and cell
debriswere removed by centrifugation at 10,000 rpm for 10min
at 4 °C. IgG-Sepharose beads (300 l) (GE Healthcare) were
placed in a 10-ml column (Thermo Fisher Scientific) and
washed with 5 ml of IPP150 (10 mM Tris, pH 8, 1% v/v Nonidet
P-40, 150 mM NaCl) buffer. Cell extract (400 l) was added to
the washed IgG beads in a final volume of 3 ml containing 10
mM Tris, pH 8, 1% v/v Nonidet P-40, 150 mM NaCl and incu-
bated on a rotator for 2 h at 4 °C. Following incubation, columns
were washed with 3  10 ml of IPP150 buffer. Washed beads
were resuspended in 333l of buffer D and 67l of 6 protein
loading buffer and boiled for 10 min at 95 °C, and 10–20 l
were used for SDS-PAGE and Western blotting. Methionine
oxidation of Sup35 and Rnq1 was detected using MetO anti-
bodies (Novus Biologicals).
RESULTS
DoNovoAggregation of Rnq1 and Sup35 Is Increased in a tsa1
tsa2Mutant—We previously used a Sup35::GFP fusion protein
to demonstrate that the de novo formation of Sup35 aggregates
is increased in a tsa1 tsa2mutant (23). In this study, we exam-
ined a range of known prion and amyloidogenic proteins to
determine whether aggregation is a common feature of such
proteins in tsa1 tsa2 mutants. Prion-forming proteins, includ-
ing Sup35, Swi1, Cyc8, Ure2, and Rnq1, were all expressed
under the control of heterologous promoters as chimeras with
GFP or YFP (see “Experimental Procedures” for details). In
agreement with previous observations, strong diffuse cytoplas-
mic fluorescence of Sup35::GFPwas observed inwild-type cells,
whereas many different sized aggregates of Sup35 were
detected in the majority (95%) of tsa1 tsa2mutant cells (Fig.
1A).
Swi1 is a chromatin-remodeling factor that has been shown
to form numerous fluorescent foci in [SWI] cells, but not in
[swi] cells (36). Fluorescence was diffuse, and no foci were
detected in the tsa1 tsa2mutant, indicating that Swi1 does not
form aggregates in this mutant (Fig. 1A). Cyc8 is a transcrip-
tional co-repressor that normally shows distinct nuclear fluo-
rescence but forms punctate fluorescent dots in its prion form
(32). Nuclear localization of Cyc8::YFP was observed in wild-
type cells, whereas fluorescence was more diffuse and less pro-
nounced in a tsa1 tsa2mutant (Fig. 1A). It is unclear why fluo-
rescence was altered in this manner in the tsa1 tsa2 mutant;
nevertheless we were unable to detect any aggregates of
Cyc8::YFP that would be indicative of prion formation. Forma-
tion of the [URE3] prion by theUre2 transcriptional repressor
has been extensively characterized as a model prion (2).
Ure2::GFP can form large fluorescent foci indicative of aggre-
gation in [URE3] strains. However, Ure2::GFPwas detected as
diffuse cytoplasmic fluorescence in both the wild-type and the
tsa1 tsa2mutant strains (Fig. 1A).
Rnq1 can form the [PIN] prion, which is known to be
required for the de novo formation of [PSI] (10). We found
that the wild-type strainW303 used in this study is [PIN], but
only 18% of cells examined showed distinct formation of
Rnq1 aggregates (data not shown). As expected, the tsa1 tsa2
mutant derived from W303 was also [PIN], although all tsa1
tsa2 mutant cells examined contained distinct Rnq1::GFP
aggregates (data not shown). To determine whether Rnq1
shows a higher propensity to aggregate in a [pin] tsa1 tsa2
mutant, theW303-based strains were cured of [PIN] by treat-
ment with GdnHCl, which inhibits Hsp104, a molecular chap-
erone that is absolutely required for yeast prion propagation
(39, 40). The resulting [pin] strains were then grown for40
generations in liquid culture, and Rnq1::GFP aggregation was
examined. Under these conditions, Rnq1 fluorescence showed
diffuse cytoplasmic staining in the wild-type [pin] strain,
whereas distinct aggregates were detected in all tsa1 tsa2
mutant cells examined (Fig. 1A).
A number of mammalian proteins that have amyloidogenic
potential have been expressed in yeast and shown to retain their
propensity to form amyloid. These include proteins that are
associated with neurodegenerative diseases such as Parkinson
disease (-synuclein) andHuntingtondisease (huntingtin) (41).
We therefore examined whether loss of TSA1 and TSA2 influ-
ences the aggregation of -synuclein and huntingtin-GFP
fusions. -Synuclein showed diffuse cytoplasmic fluorescence
in both the wild-type strain and the tsa1 tsa2 [PIN] mutant
(Fig. 1B). Expansion of the poly(Q)-encoding region of the Htt
gene beyond the critical length of 35 glutamines causes the
Htt protein to become neurotoxic and prone to aggregation.
Htt25Q::GFP showed diffuse cytoplasmic fluorescence in both
ROS-induced Formation of the Yeast [PSI ] Prion
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the wild-type and the tsa1 tsa2 [PIN] mutant strain.
Htt103Q::GFP was seen to aggregate in the wild-type strain as
expected, and 26% of cells were found to contain numerous
fluorescent foci (Fig. 1B). However, in the tsa1 tsa2 [PIN]
mutant, a similar number of cells containing aggregates (27%)
were detected. Taken together, these data indicate that Tsa1
and Tsa2 normally function to suppress the formation of both
the [PSI] and the [PIN] prions, but increased protein aggre-
gation does not appear to be a common feature of prion and
amyloidogenic proteins in tsa1 tsa2mutants.
Tsa1 and Tsa2 Protect against de Novo Formation of the
[PIN] Prion—Given that aggregation of Rnq1::GFP was
detected in the tsa1 tsa2mutant, the subcellular distribution of
Rnq1 was examined in exponential phase cultures of the wild-
type and the peroxiredoxinmutant strains. [pin] derivatives of
these strains were generated using GdnHCl and then grown for
40 generations in liquid culture to allow the de novo forma-
tion of new prions. Analysis of the resulting subcellular distri-
bution of Rnq1 revealed that the protein was in the soluble
fraction in wild-type cells but was predominantly in an SDS-
insoluble high molecular weight form in the tsa1 tsa2 mutant
(Fig. 2A). Subsequently, growing these tsa1 tsa2mutants with 3
mM GdnHCl or overexpressing an ATPase-deficient allele of
Hsp104 (hsp104::K218T,K620T) in that strain resulted in Rnq1
switching back to the soluble fraction (Fig. 2A). These data con-
firm the requirement for wild-type Hsp104 for maintaining the
Rnq1 aggregates in the tsa1 tsa2 mutant; this is an important
genetic criterion for yeast prions (2).
The 74D-694 strain used for these studies contains the
ade1-14 nonsense (UGA) mutant allele, which confers adenine
autotrophy. 74D-694 [psi] cells accumulate a red pigment,
and suppression of the ade1-14 nonsensemutation gives rise to
white/pink Ade colonies. This phenotypic change was used to
quantify the de novo formation of [PIN] as follows. Sup35NM-
GFPwas overexpressed in [psi] [pin] wild-type and tsa1 tsa2
mutant cells to detect cells that will generate [PSI] de novo.
Because [PSI] formation is dependent on cells being [PIN]
(10), one can estimate the rate of [PIN] formation based on the
number of white/pink Ade cells that arise. The rate of de novo
formation of [PIN] colonies was3% in the wild-type strain,
and this was elevated 7-fold in the tsa1 tsa2 mutant (Fig. 2B).
Furthermore, culturing strains in the presence of 100 MH2O2
for 20 h further increased the rate of de novo [PIN] prion
formation in wild-type and tsa1 tsa2 mutant cells, reaching a
rate of27% in the peroxiredoxin-deficient mutant (Fig. 2B).
De Novo Formation of the [PSI] Prion Still Depends on the
[PSI] Prion in a tsa1 tsa2 Mutant—Because the de novo for-
mation of both [PSI] (23) and [PIN] (this study) prions is
elevated in tsa1 tsa2mutants, we examined whether the loss of
TSA1 and TSA2 abrogates the requirement of cells being
[PIN] for de novo formation of the [PSI] prion. This was
achieved by deleting the RNQ1 gene in the tsa1 tsa2mutant to
prevent cells from forming the [PIN] prion. The wild-type,
tsa1 tsa2, and tsa1 tsa2 rnq1 strains were grown with 3 mM
GdnHCl before being grown for40 generations in liquid cul-
ture in the absence of GdnHCl to allow the formation of new
prions. Although white/pink Ade [PSI] colonies were gener-
ated at high frequency in the tsa1 tsa2mutant, no such colonies
were generated in the tsa1 tsa2 rnq1 mutant, confirming that
FIGURE 1. Aggregation of prion and amyloidogenic proteins in a tsa1 tsa2mutant. Representative fluorescence micrographs are shown for the TSA1/
TSA2 wild-type and tsa1 tsa2 mutant strains containing plasmid expression fusion proteins of Sup35 (Sup35NM-GFP), Swi1 (p416TEF-NQYFP), Cyc8 (CUP1-
CYC8-YFP), Ure2 (pYe2T-URE2GFP), Rnq1 (GAL1-RNQ1-EGFP), Htt (pYES2-Htt25Q-GFP and pYES2-Htt103Q-GFP) and -synuclein (pHY314-Syn-GFP). All
strains are [PIN].
ROS-induced Formation of the Yeast [PSI ] Prion
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the [PIN] prion is still required for [PSI] prion formation in
tsa1 tsa2mutants (Fig. 3A).
This result was further confirmed by examining the de novo
formation of Sup35 aggregates in [PIN] and [pin] strains
using the Sup35NM-GFP reporter construct in aW303 genetic
background. The tsa1 tsa2 rnq1 [pin] mutant of W303 was
constructed by deleting RNQ1 in a tsa1 tsa2 [PIN] mutant.
The resulting tsa1 tsa2 rnq1 [pin] mutant still generated
[PSI] cells at high frequency that contained the diagnostic
high molecular weight SDS-resistant aggregates of Sup35 that
were also observed in the tsa1 tsa2 [PIN] and control 74D-694
[PIN] [PSI] strains (Fig. 3B). In agreement with this, strong
cytoplasmic fluorescence of Sup35::GFP was observed in the
[psi] [PIN] wild-type cells, whereas many different sized
aggregates of Sup35 were detected in the majority of tsa1 tsa2
and tsa1 tsa2 rnq1 mutant cells (Fig. 3C, non-cured). As
expected, growth in the presence of 3 mM GdnHCl resulted in
Sup35::GFP shifting to cytoplasmic fluorescence in the two
mutant strains (Fig. 3C, cured), but following growth of these
cured strains in the absence of GdnHCl for 40 generations,
Sup35NM-GFP aggregates were re-formed in the tsa1 tsa2
mutant but not the tsa1 tsa2 rnq1 mutant (Fig. 3C, cured and
cultured), further confirming the requirement for Rnq1/[PIN]
for de novo [PSI] prion formation (Fig. 3B).
Sup35 Protein Oxidation Is Increased in a tsa1 tsa2 Mutant
and Correlates with Protein Aggregation—Given that oxidation
of methionine residues in purified PrPC may cause the -to-
structural conversion, which underlies the sporadic formation
of PrPSc (18, 19), we examined methionine oxidation of Sup35
and Rnq1 in the tsa1 tsa2 mutant. Sup35 and Rnq1 were
genomically tagged to enable purification from wild-type and
tsa1 tsa2 mutant strains using TAP. We first confirmed that
genomically tagging Sup35 and Rnq1 does not affect reversible
prion formation in the tagged 74D-694 tsa1 tsa2 mutant
strains. Colony-purified red Ade 74D-694 tsa1 tsa2 SUP35-
TAP and RNQ1-TAP mutant strains were streaked for single
colonies on YEPD media. For the SUP35-TAPmutant, 110 out
of 120 independently arising pink/white colonies were curable
with GdnHCl. Similarly, 108 out of 120 independently arising
pink/white colonies from the RNQ1-TAPmutant were curable
with GdnHCl, confirming reversible prion formation. Methio-
nine oxidation was detected using an antibody that recognizes
FIGURE2.Denovo formationof the [PIN[rsqb]prion is increased ina tsa1
tsa2 [pin]mutant.A, subcellular localizationof Rnq1wasexamined inwild-
type (74D-694,wt) and tsa1 tsa2mutant cells and in the same cells following
growth in the presence of GdnHCl (i.e. cured) or expressing an ATPase-defi-
cient allele ofHsp104 (hsp104::K218T,K620T). Cellsweregrown toexponential
phase in SD minimal media, and subcellular fractionation analysis of Rnq1
was performed as described under “Experimental Procedures,” using an anti-
Rnq1 polyclonal antibody. T, total crude extract; S, soluble fraction; P, pellet
fraction. B, the rate of de novo [PIN] formation was determined in the wild
type (74D-694, wt) and tsa1 tsa2 mutant as described under “Experimental
Procedures” and is expressed as the number of [PIN] colonies formed per 96
colonies examined. The rate of de novo [PIN] formation is significantly differ-
ent in the tsa1 tsa2mutant when comparedwith thewild-type strain (p value
0.05). Hydrogen peroxide exposure increased the rate of de novo [PIN]
formation in both the wild-type and the tsa1 tsa2mutant strains but was not
significant (p value 0.34 and 0.052, respectively). Error bars indicate S.E.
FIGURE 3. De novo formation of the [PSI] prion still depends on the
[PIN] prion in a tsa1 tsa2mutant. A, [PSI] prion formation was assayed in
the wild-type (74D-694, wt), tsa1 tsa2, and tsa1 tsa2 rnq1 mutant strains by
pink/white colony formation on qYEPD medium (white/gray in black and
white) and growth on minimal medium in the absence of adenine (Ade).
B, SDS-resistant Sup35 aggregates were detected in wild-type (W303), tsa1
tsa2, tsa1 tsa2 rnq1, and a [PSI] control strain using SDD-AGE. Heating cell
extracts to 95 °C for 10min collapses aggregates to themonomer form (M). C,
representative fluorescence micrographs are shown for the wild type, tsa1
tsa2, and tsa1 tsa2 rnq1mutants containing the Sup35NM-GFP plasmid.Non-
cured refers to strains that have been routinely cultured in rich growth
medium,whereas cured refers to strains thatwere analyzed following growth
with 3 mM GdnHCl. Cured and cultured refers to strains that were examined
following the growth of cured strains in the absence of GdnHCl for40 gen-
erations in liquid culture to allow the formation of new prions.
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methionine sulfoxide (MetO), and basal levels of MetO were
significantly elevated in the tsa1 tsa2 mutant when compared
with a wild-type strain (Fig. 4A).Methionine oxidation was also
further elevated following exposure to 1 mM H2O2 for 1 h. In
contrast, we could not detect any elevated methionine oxida-
tion in Rnq1 purified from the tsa1 tsa2 mutant (data not
shown).
To determine whether methionine oxidation correlates with
Sup35 aggregation, we examined whether overexpression of
methionine sulfoxide reductase (MSR) could protect against
methionine oxidation and reduce the frequency of de novo for-
mation of [PSI]. MSRs are antioxidants that protect against
Met oxidation by catalyzing thiol-dependent reduction of oxi-
dized Met residues (42). Wild-type (74D-694) and tsa1 tsa2
mutant strainswere first transformedwith aGAL1-MSRA-GST
plasmid, and then [pin] derivatives were generated by growth
with 3 mMGdnHCl. The resulting [pin] transformed colonies
were then grown in SD or SGal media for 40 generations in
liquid culture to allow the formation of new prions. Growth on
galactose was confirmed to induce the expression of MSRA as
determined by Western blot analysis, and the resulting eleva-
tion in the levels ofMSRA prevented the increased methionine
oxidation normally observed in the tsa1 tsa2mutant (Fig. 4B).
In comparison, no MSRA expression was detected in glucose-
grown cells, and elevated MetO formation was still detected in
the tsa1 tsa2mutant (Fig. 4B).
The subcellular distribution of Sup35 was used to determine
whether methionine oxidation correlates with Sup35 aggrega-
tion. Strikingly, concomitant MSRA expression prevented the
formation of SDS-resistant Sup35 aggregates in the tsa1 tsa2
mutant (Fig. 5A). Similarly, SDD-AGEwas used to confirm that
Sup35 does not form high molecular weight SDS-resistant
aggregates when MSRA is overexpressed in the tsa1 tsa2
mutant (Fig. 5B). In comparison, overexpression of MSRA did
not affect [PIN] formation because Rnq1 was largely present
in an SDS-insoluble highmolecularweight form in the tsa1 tsa2
mutant grown in glucose or galactose media (Fig. 5C). These
data indicate that methionine oxidation in Sup35 may play a
critical role in de novo formation of the [PSI] prion in tsa1 tsa2
mutants.
DISCUSSION
Weshowhere that formation of the [PIN] prion is increased
in response to oxidative stress conditions similar to the previ-
ously reported increase for the [PSI] prion (23). However, this
does not appear to be a common feature of prion and amyloido-
genic proteins because increased aggregation was not observed
FIGURE 4. Overexpression of MSRA protects Sup35 against methionine
oxidation. A, Sup35 was affinity-purified using TAP chromatography from a
wild-type and tsa1 tsa2mutant strain treatedwith 1mMH2O2 for 1 h.Western
blots were probed with -PAP to confirm that similar amounts of Sup35
were purified from each strain. Sup35 oxidationwas detected using antibod-
ies that recognize methionine sulfoxide (MetO). B, methionine sulfoxide
reductase (MSRA) was overexpressed using plasmid GAL1-MSRA-GST in wild-
type and tsa1 tsa2 mutant strains. Overexpression was confirmed under
inducing (Gal) versus repressing (Glu) conditions using an anti-GST antibody
(GST).MSRA expression preventedmethionine oxidation of Sup35 detected
using the -MetO antibody.
FIGURE5.OverexpressionofMSRAprevents [PSI] prion formation.A, the
subcellular distribution of Sup35 was determined in wild-type (74D-694, wt)
and tsa1 tsa2mutant cells containing plasmid GAL1-MSRA-GST grown under
inducing (Gal) and repressing (Glu) conditions. T, total crudeextract; S, soluble
fraction;P, pellet fraction.B, SDS-resistant Sup35aggregatesweredetected in
the same strains using SDD-AGE. A [PSI] derivative of 74D-694 is shown for
comparison. Heating cell extracts to 95 °C for 10min collapses aggregates to
the monomer form (M). C, the subcellular distribution of Rnq1 was deter-
mined in the tsa1 tsa2 mutant containing plasmid GAL1-MSRA-GST grown
under inducing (Gal) and repressing (Glu) conditions.
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for Swi1, Cyc8, Ure2, Htt, and-synuclein in tsa1 tsa2mutants.
The specificity for Sup35 and Rnq1 may reflect the localization
and/or catalytic activity of the two relevant peroxiredoxins.
Tsa1/Tsa2 are cytoplasmic antioxidants that detoxify
hydroperoxides (26, 27), and they are particularly important
during normal aerobic growth conditions because their
absence results in an increased rate of spontaneous mutations.
This indicates that Tsa1/Tsa2 normally function to protect
against endogenousROS (28). Tsa1/Tsa2 andSup35 co-localize
to ribosomes, which may explain the role of these Prxs in pro-
tecting against [PSI] prion formation (23). It is not yet known
whether Rnq1 is similarly localized, but ribosomal association
may also explain the role of Tsa1/Tsa2 in protecting against
[PIN] prion formation.More studies will be required to deter-
mine the general oxidant sensitivity of prion and amyloidogenic
proteins and whether particular antioxidants provide compart-
ment- or ROS-specific protection against protein oxidation.
[PSI] arises de novo at a frequency of5 107 per gener-
ation (43). Our data indicate that the de novo rate of [PIN]
formation (3  102) is several orders of magnitude greater
than that of [PSI]. A [pin] derivative of thewild-typeTSA1/
TSA2 readily formed the [PIN] prion, and the rate of forma-
tion was further enhanced in the tsa1 tsa2 mutant and under
oxidative stress conditions. It is known that heterologous pri-
ons can interact; for example, [PIN] promotes and enhances
the de novo appearance of [PSI] through a direct protein-pro-
tein interaction (44). The [PIN] prion is essential for the for-
mation of [PSI] in tsa1 tsa2mutants because deletion ofRNQ1
prevented [PSI] prion formation in response to oxidative
stress conditions. Although other proteins can form [PIN]
when overexpressed (11), in the majority of laboratory strains,
[PIN] is the prion form of Rnq1. The observed high rate of
[PIN] formation is consistent with the finding that nearly all
laboratory strains and a significant proportion of natural strains
are [PIN] prions (45).5 Consequently, oxidationmay only nor-
mally function to increase [PSI] prion formation.
All amino acids are potentially susceptible to oxidation by
ROS (17). Methionine residues are particularly sensitive, form-
ing a racemic mixture of methionine-S-sulfoxide and methio-
nine-R-sulfoxide in cells (17, 46). Sup35 and Rnq1 are rich in
methionine residues; Sup35 contains 19 methionine residues,
and Rnq1 contains 14 methionine residues, respectively. We
were able to detect increased Sup35 methionine oxidation in
tsa1 tsa2 mutants using an antibody that recognizes methio-
nine sulfoxide, and oxidation was further increased following
exposure to hydrogen peroxide.Most organisms containMSRs,
which protect againstmethionine oxidation by catalyzing thiol-
dependent reduction of oxidized Met residues. This is particu-
larly important because it means that methionine oxidation is
readily reversible and may play an antioxidant role in scaveng-
ing ROS (47). Yeast contains three MSR enzymes (fRMsr/
MsrA/MsrB) (42). Overexpression of MSRA protected Sup35
against methionine oxidation and also prevented [PSI] prion
formation, indicating that Sup35 methionine oxidation may
induce [PSI] prion formation. Taking these observations
together, we propose a model for ROS-induced [PSI] prion
formation shown in Fig. 6. In contrast, wewere unable to detect
any elevatedmethionine oxidation in Rnq1, andMSRA overex-
pression did not prevent [PIN] formation. Because Rnq1 is
known to directly interact with Sup35, one possibility is that the
oxidation of Sup35 directly affects the formation of [PIN]
from Rnq1. We have addressed this possibility by examining
whether oxidants can induce formation of the [PIN] prion in
the absence of [PSI] prion formation. [pin] [psi] derivatives
of the peroxiredoxinmutantwere generated usingGdnHCl and
then grown in the presence of H2O2 to promote new prion
formation.However, 6 out of 10 [PIN] strains identified in this
analysis were found to still be [psi], indicating that [PSI]
formation is not necessarily required to promote [PIN] forma-
tion in response to oxidant exposure. Further studies will be
required to determine whether oxidative modifications, or
alternatively, oxidant-induced changes in the protein homeo-
stasis network, promote [PIN] formation in the tsa1 tsa2
mutant.
Methionine oxidation may be a common feature in the
aggregation of prion and amyloidogenic proteins. For example,
similar MetO antibodies have been used to detect increased
methionine oxidation in agedmouse samples and samples from
patientswithAlzheimer disease (48). TheMetOcontent of pro-
teins is also known to increase with age in various model sys-
tems (49). Methionine oxidation of mammalian PrP has been
proposed to underlie the - structural switch that converts
PrPC to PrPSc (18, 19). Our findings with yeast prions together
with evidence suggesting up-regulation of peroxiredoxins in
the brain of mice infected with prions (50, 51) point to Prxs
playing an important antioxidant role in maintaining the solu-
bility of prion-forming proteins. Additionally, peroxiredoxins
may be important in other pathologies involving protein aggre-
gation as they are up-regulated in human brain postmortem
samples of Huntington disease (52), and peroxiredoxin-6 is5 G. L. Staniforth and M. F. Tuite, unpublished data.
FIGURE 6. Model depicting the role of Tsa1/Tsa2 in protecting Sup35
against protein oxidation and de novo [PSI] prion formation. Tsa1/2
function as ribosome-associated antioxidants, presumably to protect the
translation machinery and the emerging nascent polypeptide chain against
ROS. Anoxidative stress can causeoxidationofmethionine residues tomethi-
onine sulfoxide (Met-SO), whichmay underlie the switch from a soluble to an
aggregated form of Sup35. It remains to be established whether Met oxida-
tion occurs on the nascent Sup35 polypeptide chain or in pre-existing Sup35
proteins. MSR catalyzes thiol-dependent reduction of Met-SO, protecting
against Sup35 oxidation and aggregation. Oxidized Sup35 misfolds, and the
resulting aggregates can be targeted to the insoluble protein deposit (IPOD)
where [PIN]/Rnq1aggregatespromotedenovo formationof the [PSI] prion
(15). In the absence of [PIN]/Rnq1, Sup35 aggregates can still be formed but
are not converted to the [PSI] prion, i.e. they are non-heritable. For details,
see under “Results.”
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increased in brain tissue of patients with Alzheimer disease
(53).
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